Nintedanib (BIBF-1120) inhibits hepatocellular carcinoma growth independent of angiokinase activity

Title
Nintedanib (BIBF-1120) inhibits hepatocellular carcinoma growth independent of angiokinase activity
Authors
Keywords
-
Journal
JOURNAL OF HEPATOLOGY
Volume 61, Issue 1, Pages 89-97
Publisher
Elsevier BV
Online
2014-03-21
DOI
10.1016/j.jhep.2014.03.017

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation